NCI Designation Update: New ESAB Members
I am pleased to announce that two new members have joined the MCW Cancer Center’s External Scientific Advisory Board (ESAB).
The ESAB is made up of Cancer Center directors from NCI-Designated centers throughout the country. Their role is to provide scientific expertise to the MCW Cancer Center and to support Director Dr. Ming You through the designation process. The ESAB makes an annual visit to MCW, and this review replicates an NCI site visit as closely as possible.
Acting on the NCI’s suggestion that we add ESAB members with expertise in population sciences with emphasis on community engagement and disparities research, Cancer Center leadership and our ESAB members identified two excellent candidates.
I’m am happy to report that both Terrance (Teri) Albrecht, PhD and James R. Marshall, PhD accepted our invitation, and you can learn more about Dr. Albrecht and Dr. Marshall below. In addition to their expertise in population science, both Dr. Marshall and Dr. Albrecht serve on the NCI’s parent committee which reviews all cancer center designation applications, and on ESABs for several other cancer centers.
You can download a current roster of Cancer Center ESAB members here, updated to include Dr. Albrecht and Dr. Marshall.
As always, please let me know if you have any questions or feedback.
Terrance (Teri) Albrecht, PhD
Barbara Ann Karmanos Cancer Institute
Associate Center Director for Population Sciences
Leader of the Population Studies and Disparities Research Program at the Barbara Ann Karmanos Cancer Institute
Dr. Albrecht is Associate Center Director for Population Sciences and Leader of the Population Studies and Disparities Research Program at the Barbara Ann Karmanos Cancer Institute in Detroit, Michigan, where she directs transdisciplinary cancer research programs in clinical communication, behavior, and genetic epidemiology. She holds appointments as Professor and Division Director for Population Sciences in the Wayne State University School of Medicine, Department of Oncology and Adjunct Professor, Department of Family Medicine and Public Health Sciences.
Dr. Albrecht is the author of more than 125 scientific publications and four books. Her cancer research focuses on structures, processes and functions of social systems, and effects on health disparities. Her research program has been continuously funded by federal agencies for nearly two decades. Her work currently includes community engaged approaches to developing interventions to reduce the cancer burden disproportionately affecting older, underserved urban African American adults in Detroit.
Dr. Albrecht has served on numerous study panels for the National Institutes of Health. She served as Chair of the Community Influences on Health Behavior Standing Study Section for the NIH Center for Scientific Review (2007-2009) and is completing her four-year appointment as a member of NCI’s Subcommittee A, the parent committee that reviews all competitive initial and renewal applications from cancer centers for NCI designation and comprehensive status. She also serves as a member of the External Advisory Board for the University of Hawaii Cancer Center, and consults for other public agencies and private organizations.
James R. Marshall, PhD
Roswell Park Cancer Institute
Senior Vice President for Cancer Prevention and Population Sciences
Chair, Department of Cancer Prevention and Population Sciences
Research Professor, Department of Social and Preventive Medicine
Dr. James R. Marshall is Professor of Oncology and Senior Vice President for Cancer Prevention and Population Sciences at Roswell Park Cancer Institute in Buffalo NY. He earned a PhD in Sociology from the University of California at Los Angeles. Dr. Marshall’s research interests are diet and chemoprevention of prostate, breast, bladder, and colon cancer. He recently completed a 10 year study of selenium supplementation for men at elevated risk of prostate cancer and is conducting a clinical trial comparing the pharmacokinetics and pharmacodynamics of selenomethionine and methylselenocysteine.
Dr. Marshall is nationally renowned and respected, not only as a leader in population research, but as a Cancer Center leader. He is extremely knowledgeable about the designation process, and also currently serves on as a member of the NCI’s parent committee that reviews all competitive initial and renewal applications from cancer centers for NCI designation and comprehensive status.
Dr. Marshall also serves on ESABs at Oregon Health & Science University, University of Texas at Dallas, University of California, Irvine and University of Arkansas.
Dr. Marshall has authored or co-authored more than 250 journal publications, book chapters and abstracts. He is an Associate Editor for Cancer Epidemiology, Biomarkers & Prevention; Cancer Prevention Research and the Journal of Clinical Oncology.